pexels anni roenkae 3169299 dark scaled

Enhancing the Performance of Pharmaceutical Research

Pharmaceutical research is increasingly in the firing line. Over the past ten years or so, multiple attempts have been made by companies large and small to fix the machine: Tight productivity goals have been set, budget cuts have been implemented and spending on outsourcing and partnering has been increased. Proof-of-concept organisations have been set up to bridge the gap with clinical development; translational medicine, disease biology and biomarker units have been established to fully leverage the potential of new technologies and the progress made in molecular medicine. Once-centralised structures have been broken up into smaller units and there has been much talk of introducing a “more biotech-like culture” into pharmaceutical discovery organisations.